---
title: "VTVT.US (VTVT.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/VTVT.US/news.md"
symbol: "VTVT.US"
name: "VTVT.US"
parent: "https://longbridge.com/en/quote/VTVT.US.md"
datetime: "2026-05-20T14:45:33.857Z"
locales:
  - [en](https://longbridge.com/en/quote/VTVT.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/VTVT.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/VTVT.US/news.md)
---

# VTVT.US (VTVT.US) — Related News

### [](https://longbridge.com/en/news/286445999.md)
*2026-05-14T16:35:35.000Z*
> vTv Therapeutics shares are trading higher after the company reported better-than-expected Q1 financial results.

### [Vector Science & Therapeutics Agrees to an Option to Invest in LyoGenesis Plus, Securing Long-Term Access to FDA-Registered, cGMP Manufacturing](https://longbridge.com/en/news/286282378.md)
*2026-05-13T14:48:00.000Z*
> Vector Science & Therapeutics has entered an option agreement to invest up to $1 million for a 15% equity stake in LyoGe

### [vTv Therapeutics (VTVT) Projected to Post Earnings on Wednesday](https://longbridge.com/en/news/285927004.md)
*2026-05-11T10:49:45.000Z*
> vTv Therapeutics (NASDAQ:VTVT) is set to release its earnings on Wednesday, May 13, with analysts expecting earnings of 

### [09:26 ETVector Science & Therapeutics Files Provisional Patent for Novel Microneedle Catheter Platform for Intratumoral Drug Delivery](https://longbridge.com/en/news/284903269.md)
*2026-05-01T13:28:59.000Z*
> Vector Science & Therapeutics has filed a provisional patent for a novel microneedle catheter platform aimed at intratum